Why health workers in Gaza are injured or die at high rates

PalestinianchildrenwoundedinIsraelstrikesarebroughttoShifaHospitalinGazaCityonWednesday,Oct.11,2023. Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem




hotspot

author：explore    Page View：47
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Lawmakers consider Medicare pay reforms for doctors
Next article： 23andMe had bad news about my health. I wish a person had delivered it